- Home
- RLYB vs IMCC Comparison
RLYB vs IMCC Comparison
Compare RLYB & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLYB
- IMCC
- Stock Information
- Founded
- RLYB 2018
- IMCC 1980
- Country
- RLYB United States
- IMCC Israel
- Employees
- RLYB N/A
- IMCC N/A
- Industry
- RLYB Biotechnology: Pharmaceutical Preparations
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- RLYB Health Care
- IMCC Health Care
- Exchange
- RLYB Nasdaq
- IMCC Nasdaq
- Market Cap
- RLYB 14.4M
- IMCC 11.8M
- IPO Year
- RLYB 2021
- IMCC N/A
- Fundamental
- Price
- RLYB $0.50
- IMCC $2.81
- Analyst Decision
- RLYB Hold
- IMCC
- Analyst Count
- RLYB 3
- IMCC 0
- Target Price
- RLYB $15.00
- IMCC N/A
- AVG Volume (30 Days)
- RLYB 8.4M
- IMCC 75.2K
- Earning Date
- RLYB 08-07-2025
- IMCC 08-13-2025
- Dividend Yield
- RLYB N/A
- IMCC N/A
- EPS Growth
- RLYB N/A
- IMCC N/A
- EPS
- RLYB N/A
- IMCC N/A
- Revenue
- RLYB $848,000.00
- IMCC $37,894,737.00
- Revenue This Year
- RLYB N/A
- IMCC $47.12
- Revenue Next Year
- RLYB N/A
- IMCC $12.83
- P/E Ratio
- RLYB N/A
- IMCC N/A
- Revenue Growth
- RLYB N/A
- IMCC 12.68
- 52 Week Low
- RLYB $0.22
- IMCC $1.29
- 52 Week High
- RLYB $1.54
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- RLYB 61.32
- IMCC 46.59
- Support Level
- RLYB $0.42
- IMCC $2.90
- Resistance Level
- RLYB $0.54
- IMCC $3.21
- Average True Range (ATR)
- RLYB 0.07
- IMCC 0.34
- MACD
- RLYB 0.01
- IMCC -0.07
- Stochastic Oscillator
- RLYB 56.61
- IMCC 5.05
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.